Recent scientific advances and new regulatory approvals have expanded the treatment landscape for gynecologic malignancies, including for advanced and recurrent endometrial or cervical cancers—bringing effective therapeutic options to patient populations previously considered difficult to manage, particularly after the failure of upfront chemotherapy. This wave of innovation has included the approval of antiangiogenic agents, followed by regulatory validation of immune checkpoint inhibitors and immune-targeted combination approaches in certain patient subtypes. Additionally, emerging immune-based, antibody-based, and targeted strategies are now poised to further increase the number of effective options for patients with different subsets of endometrial and cervical cancers and allow for more personalized treatment selection strategies led by molecular profiling and tumor-based genetic testing.
In light of these significant advances in women’s health, PeerView’s expert faculty has prepared a variety of activities designed to bring clinicians the latest information on the management of gynecologic malignancies. We hope you join us to learn how to optimize outcomes for your patients.
This activity has been designed to meet the educational needs of oncologists and other clinicians involved in the management of gynecologic cancers.
Linda R. Duska, MD, MPH
Learn from one of our clinical experts by requesting a live meeting at your institution or a live virtual webinar! In the context of a small, interactive group discussion, an expert in the field will review up-to-date clinical evidence supporting the use of novel targeted, immunotherapeutic, and antibody-based strategies in gynecologic cancers, discuss the practical aspects of managing patients with advanced endometrial and cervical cancers, and give strategies for selecting the right treatment for the right patient.
Download and complete the Meeting Request Form (or complete our online form) to request a live in-person meeting or turn-key virtual meeting with our expert faculty.
By requesting a meeting, you are attesting that you have read the CME/MOC Information for this activity.
Linda R. Duska, MD, MPH
Linda R. Duska, MD, MPH, will be joined by Charles A. Leath, III, MD, MSPH, and Shannon N. Westin, MD, MPH, as presenters for this educational activity.
Linda R. Duska, MD, MPH
Linda R. Duska, MD, MPH, Charles A. Leath, III, MD, MSPH, and Shannon N. Westin, MD, MPH
This educational curriculum is supported by educational grants from Eisai Inc., GlaxoSmithKline, and Merck & Co., Inc.
Your meeting request has been submitted.
We invite you to learn more about PeerView's Institute Meetings here.